1.New Treatment Option for Recurrent Clostridium difficile Infection.
Intestinal Research 2013;11(2):149-150
No abstract available.
Clostridium
;
Clostridium difficile
2.Review of clinical and laboratory features of patients to determinethe significance of increased isolation of clostridium difficile.
Chung Hyun NAM ; Yunsop CHONG ; Oh Hun KWON ; Samuel Y LEE
Korean Journal of Clinical Pathology 1991;11(2):445-452
No abstract available.
Clostridium difficile*
;
Clostridium*
;
Humans
4.Clinical significance of clostridium difficile isolated from stoolsof inpatients.
Korean Journal of Clinical Pathology 1991;11(1):117-124
No abstract available.
Clostridium difficile*
;
Clostridium*
;
Humans
;
Inpatients*
6.Fecal Microbiota Transplantation as a Treatment of Recurrent Clostridium difficile Infection: Where Are We Now and Where Are We Heading?.
The Korean Journal of Gastroenterology 2017;69(4):203-205
No abstract available.
Clostridium difficile*
;
Clostridium*
;
Fecal Microbiota Transplantation*
;
Head*
7.SDS-PAGE profiles of clostridium difficile isolated from patientsand hospital environments.
Korean Journal of Clinical Pathology 1992;12(2):223-232
No abstract available.
Clostridium difficile*
;
Clostridium*
;
Electrophoresis, Polyacrylamide Gel*
8.SDS-PAGE profiles of clostridium difficile isolated from patientsand hospital environments.
Korean Journal of Clinical Pathology 1992;12(2):223-232
No abstract available.
Clostridium difficile*
;
Clostridium*
;
Electrophoresis, Polyacrylamide Gel*
9.Evaluation of a ChromID C. difficile Agar for the Isolation of Clostridium difficile.
Ji Sook YIM ; Seock Mi HWANG ; Myungsook KIM ; Hee Joung LIM ; Saeam SHIN ; Hae Sun CHUNG ; Heejung KIM ; Kyungwon LEE
Korean Journal of Clinical Microbiology 2012;15(3):88-91
BACKGROUND: Clostridium difficile is the main etiologic agent of antibiotic-associated diarrhea and the most common cause of hospital-acquired diarrhea. Recently, the incidence of C. difficile infections (CDI) has increased and new highly virulent C. difficile strains have emerged. Therefore, accurate and rapid diagnosis is needed. We compared the results of using chromID C. difficile (chromID CD, bioMerieux, France) with the conventional C. difficile Selective Agar (CDSA; BD, USA) for the isolation of C. difficile. METHODS: A total of 738 stool specimens of suspected CDI patients at the Severance Hospital from July to August 2011 were inoculated onto CDSA. Among them, 104 stool specimens revealed colonies on CDSA that were then re-inoculated onto chromID CD. The stool samples were stored at -20degrees C until the time of the re-inoculation. Cultured agars were interpreted after 24 hrs and 48 hrs, respectively. Species identification was performed on the basis of colony characteristics on agar plates as well as the ATB 32A system (API System SA, France). RESULTS: The recovery rates of CDSA and chromID CD were 30.1% and 77.5% after 24 hrs, and 77.5% and 98.6% after 48 hrs, respectively. All of the C. difficile isolates were recovered as typical gray/black colonies on chromID CD. CONCLUSION: The performance of chromID CD for the isolation of C. difficile was better than that of conventional CDSA. The chromID CD could provide easy and sensitive detection of C. difficile even after 24hrs of incubation.
Agar
;
Clostridium
;
Clostridium difficile
;
Diarrhea
;
Humans
;
Incidence
Result Analysis
Print
Save
E-mail